The Fellowship Council

You are here: Home / Directory of Fellowships / Display Listing Menu

Display Listing

Portland, Oregon

Program Director(s):
Michele Babicky
Jon Gerry

Return to Browse

Description:

The Providence HPB Fellowship position was created in 2008, although it has been integrated with a minimally invasive surgical (MIS) Fellowship in existence for more than 25 years. The Fellowship is intended for physicians who have completed a general surgery residency and have a particular interest in hepatobiliary and pancreatic surgery and research. The program attendings are fellowship trained in hepatobiliary and pancreatic surgery, surgical oncology, advanced laparoscopic surgery, and surgical ultrasound. The program's strengths include extensive experience in advanced open and minimally invasive surgical procedures. The practice includes both benign and malignant disease processes. Additional areas of focus include intraoperative ultrasound and surgical tumor ablation. The fellowship is two years in length. The first year is primarily clinical on the HPB service. The second year is a mixture of clinical, research, and administrative time. Clinical experiences may be arranged in colorectal, foregut, organ transplant, surgical endoscopy and/or interventional radiology, depending on the fellow’s interests. Fellows are expected to accumulate a clinical experience of 200-250 advanced HPB and GI surgeries. The fellow will interact with surgical residents, but has the first right of refusal on all HPB cases. Our program is very hands-on for the fellows, with a goal of producing graduates who are capable and comfortable performing major HPB cases independently. Research is a required component of the fellowship. Fellows are expected to initiate clinical research projects with the goal of producing at least 3 presentable/publishable projects. Fellows have access to a basic science immunology lab, a large clinical database, animate and inanimate labs, and NOTES labs. Fellows are involved in teaching residents, participating in surgical training courses, and participating in HPB Program administration. The Fellowship offers high volume of cases, academic opportunities and mentorship by leading surgeons in the fields of HPB surgery, MIS, and GI surgical oncology. The setting is Providence Portland Medical Center, a community based, academic health care center located in Portland, Oregon. The fellow will gain the necessary skills and experience required to function as an independent HPB surgeon and develop sufficient clinical, research and administrative skills to develop or build their own HPB program.  **Please note, we do not accept J1 Visa's

Basic Program Information:

  • Location: Portland, Oregon
  • Primary Program Site: Providence Portland Medical Center
  • Primary Hospital: Total bed size, # OR's, # Surgical ICU beds:
  • Secondary Program Site: Good Samaritan Hospital, Legacy Health System
  • Secondary Hospital: Total bed size, # OR's, # Surgical ICU beds:
  • Clinic locations and schedule:

    Providence Portland Medical Center

    Monday and Wednesday

  • University Affiliation:
  • School of Medicine Affiliation:
  • Year Program and/or Designation Established: 2008
  • Number of Faculty:
  • % of Program Clinical: 80
  • % of Program Research: 20

Additional Program Information:

  • Interaction with Residents: Do not share cases with residents
  • Is there a General Surgery Residency at the Primary Institution? No
  • Is there a General Surgery Residency at the Secondary Institution? No
  • Is there a curriculum in place for fellowship? Yes
  • Is there a skills lab at the institution with fellow access? Yes
  • Are there teaching conferences available for the fellow? Yes
  • Is there an evaluation tool for fellow by faculty in place? Yes
  • Is there an evaluation tool for faculty by fellow in place? Yes
  • Papers Accepted For Publication where PD was an author: 20
  • Publications that Involved Input from the Fellow: 12
  • Are funds available for the Fellow to attend conferences?

Malpractice Insurance Information:

  • The fellow(s) only works as a fellow, i.e. does not/will not have attending privileges and the program provides the following:
    Claims-based malpractice coverage including a tail for the statute of limitations

Contact Information For Questions:

Alyx Wheatcroft
Phone: 503-215-9688
Fax: 503-215-3201
Email: [email protected]
Web: http://www.providence.org/oregon/cancer

Facilities

Dry Lab
Wet lab
Library
Administrative Support
Basic Science Research
Clinical Research
Simulation Lab

Citizenship and Visa Requirements:

    US Citizens
    US Permanent Residents (Green Card)

Medical School Requirements:

    We accept graduates of U.S. or Canadian Medical Schools and Foreign Medical Schools
    We accept graduates of Foreign Medical Schools only if ECFMG Certified

Examinations and Certifications:

    Applicants must have passed the USMLE/COMLEX Step 1, 2, & 3 exams
    Applicants must have passed the USMLE/COMLEX Step 1 & 2 exams or the Medical Council of Canada Evaluation Exam (MCCEE)
    Applicants must have had at least 2 years of prior training in an ACGME accredited residency or fellowship (or Canadian equivalent)
    Applicants who are ABS or Canadian Board Eligible or Certified
    Applicants must have had at least 2 years of prior training in an AOA (American Osteopathic Association) accredited residency or fellowship
    Applicants must be AOBS (American Osteopathic Board of Surgery) eligible or certified

 

Licensure Requirements and Information:

Fellows must be eligible to obtain unrestricted medical license in the State of Oregon and must obtain that license prior to start date of Fellowship. http://www.oregon.gov/OMB/
 
Must speak fluent English (though other language skills, particularly Spanish, can be an asset).  

Accreditation Status Accreditation Period Length of Accreditation
Accredited for HPB 2022-2024 2

Fellowship Opportunity # 1

  • Number of Positions Available: 1
  • Type of Fellowship: HPB
  • Duration: 2 year
  • Start Day: August 1
  • End Day: July 31
  • Is this a salaried position? Yes
  • It is a requirement that the salary must be commensurate to a PGY 6 or greater in the same city. Does your program meet this requirement? Yes
  • Is the salary guaranteed for the year? Yes
  • Is there funding available beyond salary for meeting attendance, research, etc? Yes
  • Is the salary dependent on call? No
  • Is the Fellow on call? Yes
    What are the on call requirements?
  • What are the estimated fellow weekly work hours?
  • It is a requirement that Health Insurance be provided. Do you provide health insurance to your fellows? Yes
  • Teaching Responsibilities: Yes
  • Courses/Academic Presentations: Yes
  • Does reimbursement for the above make up part of the salary? No
  • Does the fellowship contract include a non-compete clause? No
  • What type of malpractice insurance will cover the Fellow?

Clinical Outpatient Experience

HPB Fellows will have clinical outpatient experience in the HCC clinic and Liver and Pancreas surgery clinic.

Research/Scholarship Resources

The Fellows are integral participants in our productive research program. They participate with post-doctoral researchers and research fellows in weekly research meetings and in the administration of a variety of clinical and lab based research efforts. Support available includes faculty mentors, a clinical research nurse and their co-researchers. They have unlimited access to state of the art basic science labs and our animal/cadaver procedural investigation lab.

They are fully supported for two meetings/year - and for any additional meetings where they have a presentation accepted.

Program Director(s) Detailed Information

Dr. Michele Babicky

  • At Institution Since: 2018
  • Program Director Since : 2022
  • Board Certification: Board Certified

Society Memberships

ACS

AHPBA

Other

SSO

Areas of Expertise

HPB and MIS Surgery

Teaching Qualifications

Academic Awards

Brennan Visiting Resident, Memorial Sloan-Kettering Cancer Center, October 2015

Recipient, AHPBA Research Fellowship 2011-2012

Recipient, NIH Loan Repayment Program

American College of Surgeons Excellence in Research Award

Best Oral Presentation, UCSD Surgery Research Day

MedSTARS Medical Student Research AwardMartin, Shaw, and Walker Scholarships (MS III, IV)

Dean’s Recognition, Keck School of Medicine

American Institute of Chemists Award for Outstanding Achievement in Chemistry

NINDS, NIH Research Training Award

American Chemical Society Organic Chemistry Award

CRC Press Award for Outstanding Achievement in Freshman Chemistry

Phi Beta Kappa

Gamma Sigma Epsilon, Chemistry Honor Society, Chapter President

Professional Activities

Assistant Administrative Chief Resident (2014-15)

Administrative Board, Organization of Resident Representatives, American Association of Medical Colleges (2014-Present)

Curriculum Coordinator, UCSD General Surgery Basic Science Conference

Peri-operative Services Committee (2009-2011)

Resident Physician Council, Co-chair (2010-11), Treasurer (2011-12)

American Medical Women’s Association, Chapter Secretary (2008)

Physicians for Social Responsibility, Chapter Vice-President (2008)

Tour Guide and Interviews, Keck School of Medicine Admissions

Student Surgical Interest Group

Teaching Assistant, Head and Neck Anatomy, June-August 2006

Teaching Assistant, Organic Chemistry Laboratory, January-May 2002

Summary of Qualifications

Hospital Affiliations

Medical Director, Hepatopancreatobiliary (HPB) Surgery

HPB Fellowship Program Director

Providence Portland Medical Center

4805 NE Glisan St., Suite 6N60

Portland, OR 97213

 

Legacy Good Samaritan Medical Center

2222 NW Lovejoy, Suite 601

Portland, OR 97210

 

Education

Fellow, Complex General Surgical Oncology

Memorial Sloan-Kettering Cancer Center, New York, NY

08/2016-07/2018

 

Categorical Resident, General Surgery

University of California, San Diego Medical Center, San Diego, CA

07/2008-06/2016 (Research PGY3-5, 2010-13)

 

M.D., Keck School of Medicine, University of Southern California, Los Angeles, CA

08/2004-05/2008

Publications

Washington K, Augustin T, Babicky M, Gray D, Asfaw S, Cendales L Pawlik T, Warner S, Clark C, Floyd TL.  AHPBA School of Equitable Research:  A Lesson on Our Commitment to Diversity, Equity, and Inclusion, In Submission HPB 11/2021

Tang E, Hansen PD, Newell PH, Babicky ML, Gerry J, Wu Y, Dubay CJ, Bernard BM, Rajamanickam V, Zhaoyu S, Young KH, Crittenden MR, Gough MJ. Comparative Subtyping of an Upfront Resected Cohort of Pancreatic Adenocarcinoma using immunohistochemical and RNAseq-based approaches to determine treatment unresponsive subgroups, In submission  HPB 10/2021

Babicky ML, Harper MM, Chakedis J, Cazes A, Mose ES, Jaquish DV, French RP, Childers B, Alakus H, Schmid MC, Foubert P, Miyamoto J, Holman PJ, Walterscheid ZJ, Tang CM, Varki N, Sicklick JK, Messer K, Varner JA, Waltz SE, Lowy AM. MST1R kinase accelerates pancreatic cancer progression via effects on both epithelial cells and macrophages.  2019 Jul; 38 (28):5599-5611.

Chakedis J, French R, Babicky M, Jaquish D, Mose E, Cheng P, Holman P, Howard, H, Miyamoto J, Porras P, Walterscheid Z, Schultz-Fadermrecht C, Esdar C, Schadt O, Eickhoff J, Lowy AM.  Characterization of RON protein isoforms in pancreatic cancer: implications for biology and therapeutics.  Oncotarget. 2016 Jul 19; 7(29): 45959-45975.

 Chakedis J, French R, Babicky M, Jaquish D, Howard H, Mose E, Lam R, Holman P, Miyamoto J, Walterscheid Z, Lowy AM. A novel protein isoform of the RON tyrosine kinase receptor transforms human pancreatic duct epithelial cells.  2016 Jun 23; 35(25):3249-59. 

 Alakus H, Babicky ML, Ghosh P, Yost S, Jepsen K, Dai Y, Arias A, Samuels ML, Mose ES, Schwab RB, Peterson MR, Lowy AM, Frazer KA, Harismendy O. Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin.  Genome Med. 2014 Jul 26; 6(7):53

 Sicklick, JK, Leonard SY, Babicky ML, Tang CM, Mose ES, French RP, Jaquish, DV, Hoh CK, Peterson M, Schwab R, Lowy AM. Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumors.  J Trans Med 2014 Feb 10; 12:41

 Babicky ML, Kang CM, Lowy AM. The RON receptor tyrosine kinase in pancreatic cancer pathogenesis and its potential implications for future targeted therapies.  Pancreas 2014 Mar 43(2):183-9.

 Yu, PT, Babicky, M, Jaquish, D, French, R, Marayuma, K, Mose, E, Niessen, S, Hoover, H, Shields, D, Cheresh, D, Cravatt, BF, Lowy, AM. The RON-receptor regulates pancreatic cancer cell migration through phosphorylation-dependent breakdown of the hemidesmosome.  Int J Cancer. 2012 Oct 15;131(8):1744-54.

 Barmparas, G, Inaba, K, Teixeira PG, Dubose JJ, Criscuoli M, Talving P, Plurad D, Green D, Demetriades D. Traumatic Amputations at a Level 1 Trauma Center.  Am Surg. 2010 Nov;76(11):1214-22.

 Criscuoli, ML, Nguyen, M, and Eliceiri, BP. Tumor metastasis but not tumor growth is dependent on Src-mediated vascular permeability. Blood, 2005 Feb 15;105(4):1508-14.

 

Poster Presentations

Babicky, ML, Harper, MM, Mose, E, Jaquish, D, Marayuma, K, French, R, Lowy, AM. RON Overexpression Drives Macrophage Differentiation Toward an Alternatively Activated (M2) Phenotype in a Mouse Model of Pancreatic Carcinogenesis.  American Association of Cancer Research Special Conference on Pancreas Cancer, June 20, 2012

Babicky, ML, Harper, MM, Mose, E, Jaquish, D, Marayuma, K, French, R, Lowy, AM. RON Overexpression Accelerates Tumorigenesis and Induces Metastasis in a KRAS Mutant Mouse Model of Pancreatic Cancer.  Poster of Distinction, Pancreas Club, May 19, 2012

 

Oral Presentations

Babicky, M. Institut de Recherche contre les Cancers de l’Appareil Digestif (IRCAD) Management of Acute Pancreatitis April 2021 Virtual Meeting: France

 Babicky, ML. Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Devil’s in the Details: Pancreas- Management and Mitigation of Post-operative Complications September 2021: Las Vegas, NV

 Babicky, ML. AHPBA Bernard Langer Fellows Symposium, First Five Years in Practice, August 2021: Miami, FL

 Gerry JM, Alonso E, Babicky ML, Hansen PD, Newell PH. AHPBA Hepatectomy for hepatocellular carcinoma in patients with elevated pre-operative bilirubin: An ACS-NSQIP HPB collaborative analysis. August 2020:  Miami, FL

 Babicky, ML, Harper, M, Mose, E, Jaquish, D, Marayuma, K, French, K, Lowy, AM. Targeting the RON Tyrosine Kinase Receptor in Pancreatic Cancer.  Next Generation Pathology Conference, February 12, 2013, Invited Speaker

 Babicky, ML and Lowy, AM. Targeting the RON Tyrosine Kinase Receptor in Pancreatic Cancer.  Americas Hepato-Pancreatico-Biliary Association, Research Fellowship Award Presentation, March 9, 2012

 Babicky, ML, Harper, M, Mose, E, Jaquish, D, Marayuma, K, French, K, Lowy, AM. RON OverexpressionAccelerates Tumorigenesis and Induces Metastasis in a KRAS Mutant Mouse Model of Pancreatic Cancer. American College of Surgeons, Surgical Forum, October 24, 2011

 Babicky, ML, Jaquish, D, Mose, E, Yu, PT, French, R, Lowy, AM. Combining RON and EGFR Kinase Directed Therapy Markedly Inhibits Orthotopic Pancreatic Cancer Growth, Society of University Surgeons/Association of Academic Surgeons American Surgical Congress, February 2, 2011

 Yu, PT, Babicky, ML, Jaquish, D, French, R, Lowy, AM. The RON Receptor Drives Pancreatic Cancer Cell Migration Through Phosphorylation Dependent Breakdown of the Hemidesmosome. Society of University Surgeons/Association of Academic Surgeons American Surgical Congress, February 1, 2011

 Babicky, ML, Chang, D, Lowy, AM. Lymph Node Metastasis is associated with Decreased Survival in Patients with Low Grade Mucinous Adenocarcinoma of the Appendix with Peritoneal Dissemination: An analysis of the National Cancer Institute (NCI) Survival Epidemiology and End Results (SEER) Database, Pacific Coast Surgical Association, February 19, 2011

 Criscuoli, M, Inaba K, Barmparas G, Teixeira, P, Plurad, D, Green, D, DuBose, J, Demetriades, D. Epidemiology of Traumatic Limb Amputations. USC Surgery Grand Rounds. April 18, 2008

 Criscuoli, M, Correa, A, Singh, G, Genyk, Y, Jabbour, N, Sher, L, Selby, R, Mateo, R. Diagnosis and Treatment of Hepatosplenic Post-Transplant Lymphoproliferative Disorder in a Renal Transplant Recipient.  Western Medical Student Research Forum.  Monterey, CA  February 4, 2006

Jon Gerry

  • At Institution Since: 0
  • Program Director Since : 0
  • Board Certification:

Society Memberships

Areas of Expertise

Teaching Qualifications

Summary of Qualifications

Division of Time

Percentage of Time Spent in Clinical Activity: 80%
Percentage of Time Spent in Research Activity:20%

Case Load as Reported By Fellow(s)

2 Fellow(s) performed 240 cases with 567 procedures during the 2022-2023 Fellowship Year.
2 Fellow(s) performed 266 cases with 530 procedures during the 2021-2022 Fellowship Year.

List of Contributing Faculty

Michele Babicky MD 34%
Area of Expertise
HPB
Role in Training
Clinical Surgeon, Research Advisor
   
Jon Gerry MD, FAS 33%
Area of Expertise
Role in Training
Clinical Surgeon
   
John Creasy MD 33%
Area of Expertise
Role in Training
Clinical Surgeon
   

Accreditation History

Director Program Length Start End  
Paul D Hansen HPB 2 2022 2024